VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $96,000 | -5.0% | 8,900 | 0.0% | 0.00% | – |
Q1 2022 | $101,000 | -23.5% | 8,900 | +9.9% | 0.00% | – |
Q4 2021 | $132,000 | -1.5% | 8,100 | +2.5% | 0.00% | – |
Q3 2021 | $134,000 | -15.7% | 7,900 | 0.0% | 0.00% | – |
Q2 2021 | $159,000 | +35.9% | 7,900 | 0.0% | 0.00% | – |
Q1 2021 | $117,000 | +14.7% | 7,900 | 0.0% | 0.00% | – |
Q4 2020 | $102,000 | +39.7% | 7,900 | 0.0% | 0.00% | – |
Q3 2020 | $73,000 | -37.6% | 7,900 | -8.1% | 0.00% | -100.0% |
Q3 2019 | $117,000 | -52.8% | 8,600 | -50.0% | 0.00% | 0.0% |
Q2 2019 | $248,000 | +18.7% | 17,200 | +62.3% | 0.00% | 0.0% |
Q1 2019 | $209,000 | -5.0% | 10,600 | +23.3% | 0.00% | 0.0% |
Q4 2018 | $220,000 | +5.3% | 8,600 | -18.9% | 0.00% | 0.0% |
Q3 2018 | $209,000 | 0.0% | 10,600 | -2.8% | 0.00% | 0.0% |
Q2 2018 | $209,000 | +15.5% | 10,900 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $181,000 | 0.0% | 10,900 | -1.8% | 0.00% | 0.0% |
Q4 2017 | $181,000 | 0.0% | 11,100 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $181,000 | -1.6% | 11,100 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $184,000 | +17.2% | 11,100 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $157,000 | -18.7% | 11,100 | -7.5% | 0.00% | -50.0% |
Q4 2016 | $193,000 | +22.9% | 12,000 | -38.5% | 0.00% | 0.0% |
Q1 2016 | $157,000 | -24.5% | 19,500 | -9.3% | 0.00% | 0.0% |
Q4 2015 | $208,000 | -12.2% | 21,500 | +2.4% | 0.00% | -33.3% |
Q3 2015 | $237,000 | -7.4% | 21,000 | +4.0% | 0.00% | 0.0% |
Q2 2015 | $256,000 | +43.0% | 20,200 | +5.2% | 0.00% | +50.0% |
Q1 2015 | $179,000 | -40.9% | 19,200 | -8.1% | 0.00% | -50.0% |
Q4 2014 | $303,000 | +49.3% | 20,900 | +6.6% | 0.00% | +33.3% |
Q3 2014 | $203,000 | -35.4% | 19,600 | +1.0% | 0.00% | -40.0% |
Q2 2014 | $314,000 | -0.3% | 19,400 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $315,000 | +31.2% | 19,400 | +2.1% | 0.01% | +25.0% |
Q4 2013 | $240,000 | +18.2% | 19,000 | +2.7% | 0.00% | 0.0% |
Q3 2013 | $203,000 | – | 18,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |